Provided by Tiger Trade Technology Pte. Ltd.

Novartis AG

138.70
+0.08000.06%
Post-market: 139.200.5000+0.36%19:46 EDT
Volume:1.89M
Turnover:263.70M
Market Cap:264.64B
PE:20.97
High:141.46
Open:140.58
Low:138.28
Close:138.62
52wk High:170.46
52wk Low:121.57
Shares:1.91B
Float Shares:1.85B
Volume Ratio:0.75
T/O Rate:0.10%
Dividend:4.67
Dividend Rate:3.36%
EPS(TTM):6.61
EPS(LYR):7.15
ROE:30.35%
ROA:10.25%
PB:6.37
PE(LYR):19.40

Loading ...

Argus Research Reaffirms Their Buy Rating on Novartis (NVS)

TIPRANKS
·
Jun 06

Movement Alert|Novartis Rises 3.13% in Regular Trading, Positive Cosentyx Phase 3 Data Boosts Shares Amid Broad Pharma Rally

Market Focus
·
Jun 05

Novartis Says Cosentyx Shows Sustained Remission in Phase 3 Trial

MT Newswires Live
·
Jun 04

Celcuity Says Gedatolisib Outperforms Novartis' Alpelisib Plus Fulvestrant in Phase 3 Trial

MT Newswires Live
·
Jun 03

Movement Alert|Novartis Falls 3.06% in Regular Trading, Trading at $144.97

Market Focus
·
Jun 01

Novartis's Next Prostate Cancer Therapy Could Raise Bar for Treatment -- Market Talk

Dow Jones
·
Jun 01

Novartis announces results on rPFS improvements across subgroups with Pluvicto

TIPRANKS
·
Jun 01

Experimental Novartis radiopharma drug shows promise in early study

Reuters
·
May 31

A New, Powerful Cholesterol-Lowering Drug Is on the Horizon -- WSJ

Dow Jones
·
May 28

China Commerce Ministry Says Companies Include Eli Lilly, Sanofi, Novartis, Merck - Statement

THOMSON REUTERS
·
May 22

Big Pharma Firms Denied Certiorari by Supreme Court in Medicare Pricing Case

MT Newswires Live
·
May 18

Novartis Says Prostate Cancer Treatment Lowers Progression Risk By 58%

MT Newswires Live
·
May 18

Novartis announces new data from PSMAddition

TIPRANKS
·
May 18

Dyne Can Unlock Value in Two Drug Prospects, RBC Says

MT Newswires Live
·
May 13

Novartis breaks ground on radioligand therapy manufacturing site in Texas

TIPRANKS
·
May 08

Novartis Starts Construction on Texas Cancer Therapy Manufacturing Facility

MT Newswires Live
·
May 08

Global Pharmaceutical Giants Report Robust Earnings, Increasing Investments in China

Deep News
·
May 07

Novartis Gains Canada Nod for Fabhalta in Rare Kidney Disease

MT Newswires Live
·
May 02

Novartis to Build Drug Ingredient Manufacturing Site in North Carolina

Dow Jones
·
Apr 30

Novartis AG reports results for the quarter ended March 31 - Earnings Summary

Reuters
·
Apr 28